RxDoctor Payments Data

Peter Bretzman, MD

Vascular & Interventional Radiology · Edina, MNNPI 1902884117

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.5% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Boston Scientific at 33.5% of the total.

$2,945in general payments, 2019–2025

Across 91 payments — averaging $32.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$986
  • Medtronic$720
  • Organogenesis Inc.$524
  • Siemens Medical Solutions USA, Inc.$182
  • Bard Peripheral Vascular, Inc.$149
  • Philips North America LLC$63
  • plus $320 from 10 others

What the payments were for

  • Travel & lodging$161%
  • Food & beverage$2,92999%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,945 in reported general payments places this provider in the 55th percentile of 78 vascular & interventional radiology providers in Minnesota.

See all vascular & interventional radiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$707,012
Medicare patients
292
Services billed
1,832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban44$26,528
ClopidogrelClopidogrel Bisulfate36$228
Methylprednisolone19$118
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim14$32
Naproxen13$32

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Edina

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →